Artificial intelligence and glaucoma: a lucid and comprehensive review DOI Creative Commons
Jin Yu, Lina Liang, Jiaxian Li

и другие.

Frontiers in Medicine, Год журнала: 2024, Номер 11

Опубликована: Дек. 16, 2024

Glaucoma is a pathologically irreversible eye illness in the realm of ophthalmic diseases. Because it difficult to detect concealed and non-obvious progressive changes, clinical diagnosis treatment glaucoma extremely challenging. At same time, screening monitoring for disease progression are crucial. Artificial intelligence technology has advanced rapidly all fields, particularly medicine, thanks ongoing in-depth study algorithm extension. Simultaneously, research applications machine learning deep field fast evolving. intelligence, with its numerous advantages, will raise accuracy efficiency new heights, as well significantly cut cost majority patients. This review summarizes relevant artificial glaucoma, reflects deeply on limitations difficulties current application presents promising prospects expectations other diseases such glaucoma.

Язык: Английский

Artificial Intelligence for Optical Coherence Tomography in Glaucoma DOI Creative Commons
Mak B. Djulbegovic, Henry Bair, David J. Taylor Gonzalez

и другие.

Translational Vision Science & Technology, Год журнала: 2025, Номер 14(1), С. 27 - 27

Опубликована: Янв. 24, 2025

Purpose: The integration of artificial intelligence (AI), particularly deep learning (DL), with optical coherence tomography (OCT) offers significant opportunities in the diagnosis and management glaucoma. This article explores application various DL models enhancing OCT capabilities addresses challenges associated their clinical implementation. Methods: A review articles utilizing was conducted, including convolutional neural networks (CNNs), recurrent (RNNs), generative adversarial (GANs), autoencoders, large language (LLMs). Key developments practical applications these image analysis were emphasized, context quality, glaucoma diagnosis, monitoring progression. Results: CNNs excel segmenting retinal layers detecting glaucomatous damage, whereas RNNs are effective analyzing sequential scans for disease GANs enhance quality data augmentation, autoencoders facilitate advanced feature extraction. LLMs show promise integrating textual visual comprehensive diagnostic assessments. Despite advancements, such as availability, variability, potential biases, need extensive validation persist. Conclusions: reshaping by OCT's capabilities. However, successful translation into practice requires addressing major related to fairness, model ensure accurate reliable patient care. Translational Relevance: bridges gap between basic research care demonstrating how AI, models, can markedly utility monitoring, prediction, moving toward more individualized, personalized, precise treatment strategies.

Язык: Английский

Процитировано

1

Performance of the Generative Artificial Intelligence Chatbot in Ophthalmic Registration and Clinical Diagnosis: a Cross-sectional Study (Preprint) DOI Creative Commons
Shuai Ming, Xi Yao, Xiaohong Guo

и другие.

Journal of Medical Internet Research, Год журнала: 2024, Номер 26, С. e60226 - e60226

Опубликована: Окт. 15, 2024

Background Artificial intelligence (AI) chatbots such as ChatGPT are expected to impact vision health care significantly. Their potential optimize the consultation process and diagnostic capabilities across range of ophthalmic subspecialties have yet be fully explored. Objective This study aims investigate performance AI in recommending outpatient registration diagnosing eye diseases within clinical case profiles. Methods cross-sectional used cases from Chinese Standardized Resident Training–Ophthalmology (2nd Edition). For each case, 2 profiles were created: patient with history (Hx) examination (Hx+Ex). These served independent queries for GPT-3.5 GPT-4.0 (accessed March 5 18, 2024). Similarly, 3 residents posed same a questionnaire format. The accuracy subspecialty was primarily evaluated using Hx top-ranked diagnosis top suggestions (do-not-miss diagnosis) assessed Hx+Ex gold standard judgment published, official diagnosis. Characteristics incorrect diagnoses by also analyzed. Results A total 208 12 analyzed (104 104 profiles). profiles, GPT-3.5, GPT-4.0, showed comparable (66/104, 63.5%; 81/104, 77.9%; 72/104, 69.2%, respectively; P=.07), ocular trauma, retinal diseases, strabismus amblyopia achieving accuracies. both demonstrated higher than (62/104, 59.6% 63/104, 60.6% vs 41/104, 39.4%; P=.003 P=.001, respectively). Accuracy do-not-miss improved (79/104, 76% 68/104, 65.4% 51/104, 49%; P<.001 P=.02, highest accuracies observed glaucoma; lens diseases; eyelid, lacrimal, orbital diseases. recorded fewer top-3 (25/42, 60% 53/63, 84%; P=.005) more partially correct (21/42, 50% 7/63 11%; P<.001) while had completely (27/63, 43% 7/42, 17%; less precise (22/63, 35% 5/42, 12%; P=.009). Conclusions intermediate registration. While underperformed, approached numerically surpassed differential show promise facilitating However, their integration into decision-making requires validation.

Язык: Английский

Процитировано

5

A gene-based predictive model for lymph node metastasis in cervical cancer: superior performance over imaging techniques DOI Creative Commons
Dongdong Xu, Xibo Zhao, Dongdong Ye

и другие.

Journal of Translational Medicine, Год журнала: 2025, Номер 23(1)

Опубликована: Апрель 3, 2025

Abstract Objective Lymph node metastasis (LNM) critically impacts the prognosis and treatment decisions of cervical cancer patients. The accuracy sensitivity current imaging techniques, such as CT MRI, are limited in assessing lymph status. This study aims to develop a more accurate efficient method for predicting LNM. Methods Three independent cohorts were merged divided into training internal validation groups, with our cohort those from other centers serving external validation. A predictive model LNM was established using LASSO regression multivariate logistic regression. diagnostic performance compared that CT/MRI terms accuracy, sensitivity, specificity, AUC. Results Using RNA-seq data, four genes (MAPT, EPB41L1, ACSL5, PRPF4B) identified through regression, constructed calculate risk score. Compared CT/MRI, demonstrated higher efficiency, an 0.840 0.804, CT/MRI’s 0.713 0.587. corrected 81% misdiagnoses by demonstrating significant improvements sensitivity. Conclusion developed this study, based on gene expression significantly improves preoperative assessment cancer. traditional shows superior accuracy. provides robust foundation developing precise tools, paving way future clinical applications individualized planning.

Язык: Английский

Процитировано

0

Progress in Artificial Intelligence-Assisted Fundus Photography Screening Technology for Glaucoma DOI

昕 李

Advances in Clinical Medicine, Год журнала: 2025, Номер 15(04), С. 967 - 973

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0

Artificial intelligence technology in ophthalmology public health: current applications and future directions DOI Creative Commons

ShuYuan Chen,

Wen Bai

Frontiers in Cell and Developmental Biology, Год журнала: 2025, Номер 13

Опубликована: Апрель 17, 2025

Global eye health has become a critical public challenge, with the prevalence of blindness and visual impairment expected to rise significantly in coming decades. Traditional ophthalmic systems face numerous obstacles, including uneven distribution medical resources, insufficient training for primary healthcare workers, limited awareness health. Addressing these challenges requires urgent, innovative solutions. Artificial intelligence (AI) demonstrated substantial potential enhancing across various domains. AI offers significant improvements data management, disease screening monitoring, risk prediction early warning systems, resource allocation, education patient management. These advancements substantially improve quality efficiency healthcare, particularly preventing treating prevalent conditions such as cataracts, diabetic retinopathy, glaucoma, myopia. Additionally, telemedicine mobile applications have expanded access services enhanced capabilities providers. However, there are integrating into Key issues include interoperability electronic records (EHR), security privacy, bias, algorithm transparency, ethical regulatory frameworks. Heterogeneous formats lack standardized metadata hinder seamless integration, while privacy risks necessitate advanced techniques anonymization. Data biases, stemming from racial or geographic disparities, "black box" nature models, limit reliability clinical trust. Ethical issues, ensuring accountability AI-driven decisions balancing innovation safety, further complicate implementation. The future lies overcoming barriers fully harness AI, that technology translate tangible benefits patients worldwide.

Язык: Английский

Процитировано

0

Advancements in artificial intelligence for the diagnosis and management of anterior segment diseases DOI
Kai Jin, Andrzej Grzybowski

Current Opinion in Ophthalmology, Год журнала: 2025, Номер unknown

Опубликована: Апрель 22, 2025

Purpose of review The integration artificial intelligence (AI) in the diagnosis and management anterior segment diseases has rapidly expanded, demonstrating significant potential to revolutionize clinical practice. Recent findings AI technologies, including machine learning deep models, are increasingly applied detection a variety conditions, such as corneal diseases, refractive surgery, cataract, conjunctival disorders (e.g., pterygium), trachoma, dry eye disease. By analyzing large-scale imaging data information, enhances diagnostic accuracy, predicts treatment outcomes, supports personalized patient care. Summary As models continue evolve, particularly with use large generative techniques, they will further refine planning. While challenges remain, issues related diversity model interpretability, AI's into ophthalmology promises improve healthcare making it cornerstone data-driven medical continued development application undoubtedly transform future ophthalmology, leading more efficient, accurate, individualized

Язык: Английский

Процитировано

0

Electrochemical immunosensing for rapid glaucoma disease diagnosis through simultaneous determination of SPP1 and GAS6 proteins in ocular fluids DOI

Eloy Povedano,

Raquel Rejas‐González, Ana Montero‐Calle

и другие.

Talanta, Год журнала: 2025, Номер unknown, С. 128438 - 128438

Опубликована: Июнь 1, 2025

Язык: Английский

Процитировано

0

A comparative study of GPT-4o and human ophthalmologists in glaucoma diagnosis DOI Creative Commons
Junxiu Zhang,

Yao Ma,

Rong Zhang

и другие.

Scientific Reports, Год журнала: 2024, Номер 14(1)

Опубликована: Дек. 5, 2024

Artificial intelligence (AI), particularly large language models like GPT-4o, holds promise for enhancing diagnostic accuracy in healthcare. This study evaluates the performance of GPT-4o compared to human ophthalmologists glaucoma cases. A prospective, observational was conducted at a tertiary care ophthalmology center. Twenty-six cases, including both primary and secondary types, were selected from publicly available databases institutional records. The cases analyzed by three with varying levels experience. completeness differential diagnoses assessed using 10-point 6-point Likert scales, respectively. Statistical analyses performed nonparametric methods, Kruskal–Wallis Mann–Whitney U tests. significantly less accurate diagnosis ophthalmologists. Specifically, achieved mean score 5.500 (p < 0.001) Doctor C, who had highest 8.038 0.001). Completeness scores 3.077 also lower than B, lowest 3.615 among However, diagnosis, (7.577) showed comparable (7.615) C (7.673) 0.0001) while achieving (4.096), outperforming (3.846), (2.923), B (2.808) 0.0001). AI, is currently not an acceptable standalone method diagnosing due its clinicians. These findings suggest that could serve as valuable adjunct clinical practice, complex but should replace expertise, especially initial diagnoses. Future improvements AI enhance their utility ophthalmology.

Язык: Английский

Процитировано

2

Artificial intelligence and glaucoma: a lucid and comprehensive review DOI Creative Commons
Jin Yu, Lina Liang, Jiaxian Li

и другие.

Frontiers in Medicine, Год журнала: 2024, Номер 11

Опубликована: Дек. 16, 2024

Glaucoma is a pathologically irreversible eye illness in the realm of ophthalmic diseases. Because it difficult to detect concealed and non-obvious progressive changes, clinical diagnosis treatment glaucoma extremely challenging. At same time, screening monitoring for disease progression are crucial. Artificial intelligence technology has advanced rapidly all fields, particularly medicine, thanks ongoing in-depth study algorithm extension. Simultaneously, research applications machine learning deep field fast evolving. intelligence, with its numerous advantages, will raise accuracy efficiency new heights, as well significantly cut cost majority patients. This review summarizes relevant artificial glaucoma, reflects deeply on limitations difficulties current application presents promising prospects expectations other diseases such glaucoma.

Язык: Английский

Процитировано

0